Neurons affected in Alzheimer's disease (AD) experience mitochondrial dysfunction and a bioenergetic deficit that occurs early and promotes the diseasedefining amyloid beta peptide (Ab) and Tau pathologies. Emerging findings suggest that the autophagy/lysosome pathway that removes damaged mitochondria (mitophagy) is also compromised in AD, resulting in the accumulation of dysfunctional mitochondria. Results in animal and cellular models of AD and in patients with sporadic late-onset AD suggest that impaired mitophagy contributes to synaptic dysfunction and cognitive deficits by triggering Ab and Tau accumulation through increases in oxidative damage and cellular energy deficits; these, in turn, impair mitophagy. Interventions that bolster mitochondrial health and/or stimulate mitophagy may therefore forestall the neurodegenerative process in AD.
Early Clues [ 4 8 9 _ T D $ D I F F ] That Mitochondria Are Central to AD
AD is the most common form of dementia and is characterized by a progression from episodic memory problems to severe cognitive decline and complete dependence of the patient on caregivers [1] [2] [3] . The disease-defining histopathological abnormalities -extracellular deposits of Ab and intraneuronal accumulation of hyperphosphorylated Tau (pTau) -'spread' through the brain in a nonrandom manner with early pathology occurring in the entorhinal cortex and hippocampus [4, 5] . However, the alterations in cellular homeostasis that lead to the Ab and pTau pathologies are unclear.
A widely documented abnormality in neuronal physiology that occurs before the onset of discernible cognitive deficits in those who develop AD is impaired glucose utilization as evaluated by 2-deoxy-D-glucose positron emission tomography (2DG-PET) brain imaging [6] . Disrupted mitochondrial health and neuronal metabolism as early features of AD were proposed as early as 1991 by Blass and Gibson [7] . More recently, however, there have been hundreds of studies documenting mitochondrial abnormalities in AD and elucidating the underlying molecular mechanisms and cellular consequences of mitochondrial deficits. Notably, in 2004 Swerdlow and Khan proposed a 'mitochondrial cascade hypothesis', which stated that each individual's genetically determined and environmentally influenced mitochondrial function [ 4 9 0 _ T D $ D I F F ] is the primary factor influencing late-onset AD pathology [8] . Here we review emerging findings suggesting that neurons affected in AD accumulate dysfunctional mitochondria in part due to impaired mitophagy, the process by which cells normally detect and remove mitochondria that have suffered molecular damage.
Trends
Mitochondrial homeostasis is important for synaptic plasticity, learning, and memory.
Neurons affected in Alzheimer's disease (AD) exhibit dysfunctional mitochondria.
Mitophagy plays important roles in mitochondrial homeostasis, neuroprotection, and resistance to neurodegeneration.
Induced pluripotent stem cell-derived neurons and animal models of sporadic AD provide powerful tools to investigate mitochondrial dysfunction and mitophagy 
